Ompekimig
Ompekimig is an immunoglobulin monoclonal antibody that targets IL-4, IL-13, IL-33. Ompekimig shows potential for use in immune-mediated inflammatory diseases such as asthma and atopic dermatitis.
For research use only. We do not sell to patients.
- CAS No.: 2981477-39-6
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Isotype
immunoglobulin (L-kappa-H-gamma1(_L-VH-G1(CH1-h))_L-kappa)_( H-gamma1_L-kappa)
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
[1]|
IL-4 |
IL-13 |
IL-33 |
In Vitro
Ompekimig is an antibody against hIL-4, hIL-13, and hIL-33[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Gene ID
Accession
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Fab-kappa_IgG1-kappa_disulfide
Application
ELISA, FACS, Functional assay
Chemical Information
-
CAS No. 2981477-39-6
-
SMILES
N/A
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
TPA/Croton Oil Ear Edema and Dermatitis
The TPA (12-O-tetradecanoylphorbol-13-acetate) and croton oil-induced mouse ear edema model is a well-established acute cutaneous inflammation system used to evaluate topical anti-inflammatory activity by measuring edema formation, neutrophil infiltration, vascular permeability, and cytokine-mediated skin responses in vivo. The inflammatory response is triggered by topical application of phorbol esters (TPA) or croton oil constituents, leading to rapid activation of protein kinase C signaling, leukocyte recruitment, and increased vascular permeability, which can be quantified by ear thickness, weight, dye extravasation, and biochemical markers such as myeloperoxidase (MPO) activity and pro-inflammatory mediators in ear tissue homogenates. This model is widely used for screening anti-inflammatory agents, where reductions in edema and inflammatory biomarkers reflect suppression of acute dermal inflammation and immune cell infiltration. Histological evaluation typically confirms epidermal
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Ompekimig
- 2981477-39-6
- Interleukin Related
- heavy chain amino acid sequences
- light chain amino acid sequences
- N-terminal glutaminyl cyclization
- fucosylated complex bi-antennary CHO-type N-glycosylation
- disulfide bridges
- post-translational modifications
- monoclonal antibody
- C-terminal lysine clipping
- N-terminal cyclization
- N-glycosylation
- Inhibitor
- inhibitor
- inhibit